BSECompany Update3d ago · 11 Aug 2026, 04:01 pm
AS PER THE DOCUMENT ATTACHED
Continental Chemicals Ltd · 506935
✦ AI SummaryFundraise
Continental Chemicals Ltd has submitted a statement of deviation and variation in the utilization of funds raised through a preferential issue for the quarter ended June 2026, as per Regulation 32 of SEBI (LODR) Regulations, 2015.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Continental Chemicals Ltd - 506935 - STATEMENT OF DEVIATION AND VARIATION FOR JUNE 2026
Attachments (1)
📄pdf
Download →
eb310f33-8a9d-4c24-be68-ddd4a8523a04.pdf
View document text
ondinental
b Tel. :91-120-2423316
E-mail : info@continentalsoft.com
: nke@eontinentalsoft.com
@hgm i t al5 Zfith Web : www.continentalchemicalsitd.com
CIN : L24723UP1984PLCO14171
Regd. & Head Office : A-7, Sector-7, Noida:2013C1 (U.P.) India
Date: 11.08.2026
General Manager,
Bombay Stock Exchange Limited,
Phiroze Jeejeebhoy Tower,
Dalal Street,
Fort Mumbai,
Mabharashtra-400001
Scrip Code- 506935
ISIN- INE423K01015
Subject: Submission of Statement of Deviation under Regulation 32 of SEBI (LODR)
Regulations, 2015 for the quarter ended 30™ June, 2026:
Dear Sir,
Pursuant to regulation 32 of SEBI (LODR) Regulations, 2015, please find attached Statement of
deviation and variation of utilization of fund raised through preferential issue for the quarter
ended 30% June, 2026.
This is for your information and records.
Thanking you,
Your faithfully,
For Continental Chemicals Limited
Sakshi Dhawan ettty
Sakshi Dhawan
Company Secretary
(Membership No: ACS 33279)
Continental/ 14
Chemicals Lid
Regd. & Head Office : A-7, Sector-7, Noida-201301 (U.P.) India
< el. :91-120-2423316
E-mail : info@continentalsoft.com
: nkc@continentalsoft.com
Web : www.continentalchemicalsitd.com
CIN :L24123UP1984PLC014111
GST No. : 09AAACC1412B2ZH
Annexure-A
Statement of Deviation / Variation in utilization of funds raised
Continental Chemicals
Name of listed entity
Limited
Preferential Issues
Mode of Fund Raising
Date of Raising Funds 14/10/2019
Amount Raised 1,62,50,000
Report filed for Quarter ended 30/06/2026
Monitoring Agency Not Applicable
Monitoring Agency Name, if Not Applicable
applicable
Is there a Deviation / Variation in | No
use of funds
raised
If yes, whether the same is Not Applicable
pursuant to change in terms ofa
contract or objects, which was
approved by the shareholders
If Yes, Date of shareholder Not Applicable
Approval
Explanation for the Deviation / Not Applicable
Variation
Comments of the Audit Committee Reviewed and Approved
after review
by audit committee
Comments of the auditors, if any Not Applicable
Objects for which funds have been Company has required
raised and where there has been a the funds for working
deviation, in the following table capital
Original Object Modified Object, if any O 1 rigina | M ieo dd if UF tu in ld is se d | oA fm ount
Allocat | allocat Deviation/
ion ion, if Variation
any for the
quarter
according
applicable
object
Company has required the funds Not Applicable 1,62,50 | Not " 0
,000 Applic
for working capital
able
Page1of2 AN
note
below
* Note: Please note that the funds have been fully utilized in the quarter ended 31/12/2023
Deviation or variation could mean:
(a) Deviation in the objects or purposes for which the funds have been raised or
(b) Deviation in the amount of funds actually utilized as against what was originally disclosed or
(c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer,
Name of Signatory: Naresh Kumar Chibba
Designation: Managing Director
Date: 11.08.2026
Page 2 of 2